Simulations Plus Return on Tangible Equity 2010-2024 | SLP
Current and historical return on tangible equity values for Simulations Plus (SLP) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Simulations Plus Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2024-02-29 |
$0.01B |
$0.14B |
8.16% |
| 2023-11-30 |
$0.01B |
$0.13B |
8.18% |
| 2023-08-31 |
$0.01B |
$0.13B |
7.18% |
| 2023-05-31 |
$0.01B |
$0.14B |
6.93% |
| 2023-02-28 |
$0.01B |
$0.14B |
6.85% |
| 2022-11-30 |
$0.01B |
$0.15B |
6.78% |
| 2022-08-31 |
$0.01B |
$0.15B |
8.30% |
| 2022-05-31 |
$0.01B |
$0.15B |
7.79% |
| 2022-02-28 |
$0.01B |
$0.14B |
7.97% |
| 2021-11-30 |
$0.01B |
$0.14B |
7.39% |
| 2021-08-31 |
$0.01B |
$0.14B |
6.81% |
| 2021-05-31 |
$0.01B |
$0.14B |
8.51% |
| 2021-02-28 |
$0.01B |
$0.13B |
10.10% |
| 2020-11-30 |
$0.01B |
$0.13B |
12.50% |
| 2020-08-31 |
$0.01B |
$0.12B |
19.78% |
| 2020-05-31 |
$0.01B |
$0.01B |
46.75% |
| 2020-02-29 |
$0.01B |
$0.02B |
45.00% |
| 2019-11-30 |
$0.01B |
$0.02B |
50.70% |
| 2019-08-31 |
$0.01B |
$0.02B |
57.14% |
| 2019-05-31 |
$0.01B |
$0.02B |
57.14% |
| 2019-02-28 |
$0.01B |
$0.01B |
56.00% |
| 2018-11-30 |
$0.01B |
$0.01B |
71.11% |
| 2018-08-31 |
$0.01B |
$0.01B |
84.21% |
| 2018-05-31 |
$0.01B |
$0.01B |
103.23% |
| 2018-02-28 |
$0.01B |
$0.01B |
91.43% |
| 2017-11-30 |
$0.01B |
$0.01B |
61.54% |
| 2017-08-31 |
$0.01B |
$0.01B |
43.48% |
| 2017-05-31 |
$0.01B |
$0.02B |
37.74% |
| 2017-02-28 |
$0.01B |
$0.01B |
40.82% |
| 2016-11-30 |
$0.01B |
$0.01B |
44.44% |
| 2016-08-31 |
$0.01B |
$0.01B |
48.78% |
| 2016-05-31 |
$0.00B |
$0.01B |
43.24% |
| 2016-02-29 |
$0.00B |
$0.01B |
47.06% |
| 2015-11-30 |
$0.00B |
$0.01B |
50.00% |
| 2015-08-31 |
$0.00B |
$0.01B |
55.17% |
| 2015-05-31 |
$0.00B |
$0.01B |
51.61% |
| 2015-02-28 |
$0.00B |
$0.01B |
36.36% |
| 2014-11-30 |
$0.00B |
$0.01B |
30.00% |
| 2014-08-31 |
$0.00B |
$0.01B |
25.00% |
| 2014-05-31 |
$0.00B |
$0.01B |
23.08% |
| 2014-02-28 |
$0.00B |
$0.01B |
21.43% |
| 2013-11-30 |
$0.00B |
$0.01B |
21.43% |
| 2013-08-31 |
$0.00B |
$0.01B |
21.05% |
| 2013-05-31 |
$0.00B |
$0.01B |
20.69% |
| 2013-02-28 |
$0.00B |
$0.01B |
20.00% |
| 2012-11-30 |
$0.00B |
$0.02B |
19.67% |
| 2012-08-31 |
$0.00B |
$0.02B |
19.67% |
| 2012-05-31 |
$0.00B |
$0.02B |
20.00% |
| 2012-02-29 |
$0.00B |
$0.02B |
20.69% |
| 2011-11-30 |
$0.00B |
$0.02B |
21.43% |
| 2011-08-31 |
$0.00B |
$0.01B |
22.64% |
| 2011-05-31 |
$0.00B |
$0.01B |
23.08% |
| 2011-02-28 |
$0.00B |
$0.01B |
23.53% |
| 2010-11-30 |
$0.00B |
$0.01B |
24.49% |
| 2010-08-31 |
$0.00B |
$0.01B |
16.67% |
| 2010-05-31 |
$0.00B |
$0.01B |
17.39% |
| 2010-02-28 |
$0.00B |
$0.01B |
18.18% |
| 2009-11-30 |
$0.00B |
$0.01B |
9.30% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.926B |
$0.060B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
